Nishikawa et al. [42] found that GNAS mutation could increase the expression levels of MUC2, MUC5AC, and cyclic adenosine monophosphate (cAMP) in colon cancer cells, and this process could be reversed by Protein Kinase A (PKA) inhibitors. This evidence concerns the gene MUC5AC and malignant colon neoplasm.